Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Simulations Plus, a developer of drug discovery and development simulation and modeling software, has launched DDDPlus 3.0, a major update to its software that simulates in vitro dissolution experiments to assist pharmaceutical formulation scientists in the design of new dosage forms and new experimental conditions.
Subscribe to our email newsletter
Walt Woltosz, chairman and CEO of Simulations Plus, said: “DDDPlus remains the only program of its kind in the world today. DDDPlus saves time and money.
Rather than an iterative process of design-experiment-design-experiment, DDDPlus enables formulation scientists to run a single experiment to calibrate the model for a particular type of dosage form, and then to use simulations to investigate which changes in the formulation or in the experiment will achieve the desired results.”